CONTENTS
managing editor
julia aalbers
Tel: 021 976 4378
Fax: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
Tel: 021 785 7178
Fax: 086 628 1197
e-mail:
Editorial Assistant &
Circulation
ELSABÉ BURMEISTER
Tel: 021 976 8129
e-mail:
Production
Co-ordinator
WENDY WEGENER
Tel: (021) 976-4378
e-mail:
GAUTENG CONTRIBUTOR
PETER WAGENAAR
Cell 082 413 9954
e-mail :
Editorial BOARD
The
Cardiovascular Journal of Africa
,
incorporating the
Cardiovascular
Journal of South Africa
, is published six
times a year, the deemed publication
date being the seventh day of the
second designated month,
i.e. 7 February, 7 April, 7 June, 7
August and 7 October.
Copyright:
Clinics Cardive Publishing, Pty, Ltd.
Layout:
Martingraphix
Printer:
Durbanville Commercial Printers
All submissions to CVJA are to be
made online via
Electronic submission by means of an
e-mail attachment may be considered
under exceptional circumstances.
Postal address: PO Box 1013,
Durbanville, 7551
Tel/Fax: 021 976 8129
Int.: +27 21 976 8129
e-mail:
Electronic abstracts available on
Pubmed
Audited circulation
Full text articles available on:
or via
co.za; for access codes contact
User ID: cvja8
Password: cvja8
Subscriptions for six issues:
South Africa: R300 (excl VAT)
Other African countries: $30
Overseas: Institutions: R845 ($82)
Individuals: R1 080 ($105)
The views and opinions expressed
in the articles and reviews published
are those of the authors and do not
necessarily reflect those of the editors
of the Journal or its sponsors. In all
clinical instances, medical practitioners
are referred to the product insert
documentation as approved by the
relevant control authorities.
VOL 22, NO 3. MAY / JUNE 2011
Case Reports
141 Aberrant pathway in an anomaly: pre-excitation syndrome in association with coronary
sinus aneurysm
F Aziz • R Kanal • S Butt • S Penupolu • A Ameen
143 Mycotic pseudoaneurysm of the ascending aorta following purulent pericardial effusion
diagnosed by multi-slice computed tomography
B Erkut • N Becit • M Kantarci • N Ceviz
145 Cardiogenic shock due to dynamic left ventricular outflow tract obstruction of acute
myocardial infarction: an under-diagnosed complication
CY Karabay • G Kocabay • A Kalayci • R Zehï̇
r • M Mert • C Kï̇
Review Article
147 Once fat was fat and that was that: our changing perspectives on adipose tissue
WF Ferris • NJ Crowther
Your life and Your Heart
157 The management of tobacco smoking
P Wagenaar
Drug Trends
161 Serving diabetes and cardiology: round three of the South African diabetologist/
cardiologist debate
J Aalbers
164 RE-LY trial: new sub-analyses highlight stroke
reduction in all types of non-valvular atrial
fibrillation
167 New telmisartan/amlodipine single-pill
combination offers both efficacy and tolerability
J Aalbers
168 Prasugrel study addresses timing of
thienopyridine loading dose in NSTEMI patients
pre-PCI (the ACCOAST study)
J Aalbers
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
